Boothbay Fund Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,205	Closed	-$294K	–	2444
2025 Q3	$294K	Sell	11,205 -23,030	-67%	-$687K	0.01%	1464
2025 Q2	$907K	Buy	34,235 +18,200	+114%	+$479K	0.03%	716
2025 Q1	$387K	Buy	+16,035	New	+$507K	0.01%	959
2024 Q4	–	Hold	0	–	–	–	1994
2024 Q3	–	Sell	-61,790	Closed	-$3.63M	–	2021
2024 Q2	$3.28M	Buy	61,790 +50,097	+428%	+$3.28M	0.1%	341
2024 Q1	$959K	Buy	+11,693	New	+$520K	0.03%	768
2023 Q2	–	Sell	-15,513	Closed	-$258K	–	2403
2023 Q1	$258K	Sell	15,513 -36,813	-70%	-$380K	0.01%	1594
2022 Q4	$492K	Buy	52,326 +2,981	+6%	+$13.3K	0.02%	1183
2022 Q3	$134K	Sell	49,345 -53,768	-52%	-$176K	﹤0.01%	1970
2022 Q2	$298K	Buy	103,113 +42,706	+71%	+$106K	0.01%	1469
2022 Q1	$181K	Buy	60,407 +11,127	+23%	+$39.9K	0.01%	1919
2021 Q4	$227K	Hold	49,280	–	–	0.01%	1424
2021 Q3	$309K	Sell	49,280 -27,056	-35%	-$167K	0.01%	1314
2021 Q2	$457K	Sell	76,336 -8,804	-10%	-$52.3K	0.02%	1052
2021 Q1	$539K	Buy	+85,140	New	+$599K	0.03%	904
2020 Q2	–	Sell	-24,016	Closed	-$112K	–	1162
2020 Q1	$112K	Hold	24,016	–	–	0.01%	718
2019 Q4	$193K	Buy	+24,016	New	+$175K	0.02%	713
2019 Q2	–	Hold	0	–	–	–	950
2019 Q1	–	Hold	0	–	–	–	936
2018 Q4	–	Hold	0	–	–	–	965
2018 Q3	–	Sell	-23,333	Closed	-$278K	–	1014
2018 Q2	$221K	Buy	+23,333	New	+$155K	0.03%	590
2018 Q1	–	Sell	-53,158	Closed	-$216K	–	919
2017 Q4	$216K	Buy	+53,158	New	+$154K	0.04%	568